Elkfork Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $1.38M | Hold |
9,702
| – | – | 0.03% | 323 |
|
2019
Q2 | $1.21M | Hold |
9,702
| – | – | 0.03% | 355 |
|
2019
Q1 | $1.07M | Hold |
9,702
| – | – | 0.03% | 364 |
|
2018
Q4 | $951K | Buy |
9,702
+286
| +3% | +$28K | 0.03% | 360 |
|
2018
Q3 | $1.16M | Buy |
9,416
+1,760
| +23% | +$217K | 0.03% | 345 |
|
2018
Q2 | $760K | Hold |
7,656
| – | – | 0.02% | 415 |
|
2018
Q1 | $676K | Hold |
7,656
| – | – | 0.02% | 441 |
|
2017
Q4 | $755K | Buy |
7,656
+1,188
| +18% | +$117K | 0.02% | 423 |
|
2017
Q3 | $623K | Buy |
6,468
+902
| +16% | +$86.9K | 0.02% | 435 |
|
2017
Q2 | $526K | Buy |
5,566
+2,178
| +64% | +$206K | 0.02% | 484 |
|
2017
Q1 | $277K | Buy |
3,388
+506
| +18% | +$41.4K | 0.01% | 544 |
|
2016
Q4 | $245K | Buy |
+2,882
| New | +$245K | 0.01% | 534 |
|